Low dose venetoclax plus itraconazole outpatient induction in newly diagnosed acute myeloid leukemia: A phase 2 study

Overview of attention for article published in Leukemia Research, August 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#25 of 2,146)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 36 X posts from 36 X users, with an upper bound of 117,693 followers.

RT @GomezDLeonMD: Venetoclax is an expensive life-saving drug in AML. We have proven it can be effectively reduced to 100 mg when combin…

New drugs-old tricks! Felicitaciones @GomezDLeonMD

RT @GomezDLeonMD: Venetoclax is an expensive life-saving drug in AML. We have proven it can be effectively reduced to 100 mg when combin…

RT @GomezDLeonMD: Venetoclax is an expensive life-saving drug in AML. We have proven it can be effectively reduced to 100 mg when combin…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 32 additional X posts.